Heart Test Laboratories Inc. (NASDAQ: HSCS) started the day on Thursday, with a price increase of 7.43% at $0.11, before settling in for the price of $0.10 at the close. Taking a more long-term approach, HSCS posted a 52-week range of $0.09-$1.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -56.05% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 75.00%. This publicly-traded company’s shares outstanding now amounts to $65.56 million, simultaneously with a float of $44.37 million. The organization now has a market capitalization sitting at $7.11 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1192, while the 200-day Moving Average is $0.3648.
Heart Test Laboratories Inc. (HSCS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Heart Test Laboratories Inc.’s current insider ownership accounts for 32.33%, in contrast to 1.84% institutional ownership.
Heart Test Laboratories Inc. (HSCS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 11.83 per share during the current fiscal year.
Heart Test Laboratories Inc.’s EPS increase for this current 12-month fiscal period is 75.00% and is forecasted to reach -0.10 in the upcoming year.
Heart Test Laboratories Inc. (NASDAQ: HSCS) Trading Performance Indicators
Let’s observe the current performance indicators for Heart Test Laboratories Inc. (HSCS). It’s Quick Ratio in the last reported quarter now stands at 4.32. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 355.66.
In the same vein, HSCS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.10 at the market close of one year from today.
Technical Analysis of Heart Test Laboratories Inc. (HSCS)
If we take a close look at the recent performances of Heart Test Laboratories Inc. (NASDAQ: HSCS), its last 5-days Average volume was 1.01 million that shows plunge from its year to date volume of 2.51 million. During the previous 9 days, stock’s Stochastic %D was recorded 47.46% While, its Average True Range was 0.0091.
Raw Stochastic average of Heart Test Laboratories Inc. (HSCS) in the period of the previous 100 days is set at 9.02%, which indicates a major fall in contrast to 61.02% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 57.43% that was lower than 112.49% volatility it exhibited in the past 100-days period.
